Stephen Huhn
Directeur Technique/Scientifique/R&D chez CONTINEUM THERAPEUTICS, INC.
Fortune : - $ au 31/05/2024
Profil
Stephen L.
Huhn is currently the Chief Medical Officer & SVP-Clinical Development at Contineum Therapeutics, Inc. He previously worked as an Associate Professor-Neurosurgery at Stanford University.
From 2015 to 2016, he served as the Chief Medical Officer & VP-Clinical Research at StemCells, Inc. Dr. Huhn obtained his doctorate degree from the University of Arizona in 1987.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/05/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Postes actifs de Stephen Huhn
| Sociétés | Poste | Début |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2020 |
Anciens postes connus de Stephen Huhn
| Sociétés | Poste | Fin |
|---|---|---|
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Directeur Technique/Scientifique/R&D | 01/01/2016 |
| Stanford University | Corporate Officer/Principal | - |
Formation de Stephen Huhn
| University of Arizona | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CONTINEUM THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
